<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>, particularly anticardiolipin antibodies (aCL) are autoantibodies frequently detected in the serum of patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and the primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>These patients commonly suffer from <z:mp ids='MP_0005048'>thrombosis</z:mp>, recurrent fetal loss and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Since platelet aggregation is pivotal in the genesis of <z:mp ids='MP_0005048'>thrombosis</z:mp>, we tested the hypothesis that perturbation of platelet membrane by aCL/beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> (aCL/beta 2GP) complex could trigger the biosynthesis of <z:chebi fb="0" ids="15627">TXA2</z:chebi>, a proaggregatory metabolite of AA </plain></SENT>
<SENT sid="3" pm="."><plain>The preincubation of <z:chebi fb="32" ids="36927">14C</z:chebi>-<z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> (<z:chebi fb="32" ids="36927">14C</z:chebi>-AA)-labeled platelet pellets (<z:chebi fb="32" ids="36927">14C</z:chebi>-PP) from <z:mpath ids='MPATH_458'>normal</z:mpath> individuals with aCL alone followed by incubation with thrombin, resulted in a moderate increase in platelet <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> (<z:chebi fb="32" ids="36927">14C</z:chebi>-<z:chebi fb="0" ids="28728">TXB2</z:chebi>) biosynthesis when compared to controls (without aCL) </plain></SENT>
<SENT sid="4" pm="."><plain>Similar incubations with beta 2GP-I alone resulted in negligible <z:chebi fb="32" ids="36927">14C</z:chebi>-<z:chebi fb="0" ids="28728">TXB2</z:chebi> biosynthesis </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, the preincubations of <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="32" ids="36927">14C</z:chebi>-PP with aCL/beta 2GP-I complex resulted in marked thrombin-induced <z:chebi fb="0" ids="28728">TXB2</z:chebi> biosynthesis, underscoring the requirement of beta 2GP-I in aCL-induced platelet <z:chebi fb="0" ids="28728">TXB2</z:chebi> biosynthesis </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, these results are consistent with the view that aCL/beta 2GP-I platelet interactions do play a role, at least in part, in platelet <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
</text></document>